filmov
tv
Lisa's DLBCL Story
Показать описание
00:00 Introduction
00:18 Diagnosis and Treatment Specifics
02:11: Making Treatment Decisions
03:10: Coping with Chemotherapy, Side Effects
06:06: Coping with Recurrences
06:56: CAR T Cell Therapy
07:54: Getting Support
08:17 Additional Resources
0:36:21
Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient Story
0:23:51
Nicole's Hodgkin Lymphoma Story: 'I Just Didn't Feel Right' | The Patient Story
1:07:08
Surinder K. Puri Memorial Lecture - Lisa Rimsza, MD
0:01:58
Cancer Survivor Story: How to Advocate for Yourself as a Patient | The Patient Story
1:58:31
New Options for Non-Hodgkin Lymphoma: Patients & Doctors Discuss the Latest LIVE!| The Patient S...
0:43:40
Polatuzumab Vedotin in PreviouslyUntreated Diffuse Large B-Cell Lymphoma.
0:03:08
Zarina's Story
0:04:40
Maintenance Therapy In Lymphoma with Dr. Ann S. LaCasce | Everything You Need to Know
0:04:56
Catherine Diefenbach: Polatuzumab Vedotin for Follicular Lymphoma
0:18:50
Maintenance Therapy: Is it of value in Advanced diffuse large B-cell lymphoma?
0:20:48
Current Upfront Management of DLBCL
2:21:04
aggressive lymphoma SOHO 2021 Better quality
0:15:17
What is the best therapy for primary mediastinal diffuse large B-cell lymphoma
3:18:07
Day 2: Challenges in managing Lymphomas in 2022
0:15:32
Panel discussion on mantle cell lymphoma
0:52:39
Real World Outcomes of CAR T Therapy – Experiences from Different Continents
1:06:17
Novel Therapies in Aggressive Lymphoma & CAR T-cell Therapy
1:15:08
Indolent Lymphomas - Novel Therapies Update
0:23:28
Richter’s syndrome: What are the options?
0:23:02
Dr. Kevin Hay - CAR T-Cell Therapy
0:58:17
Anderson MA (2013): Targeting Bcl-2 in the treatment of leukemia and lymphoma
1:01:00
Encore - Hematologic Malignancies (Lunch 'n Learn with the Doctors)
0:10:10
Priority Review Designation in PMBCL and 2017 SABCS and ASH Annual Meeting Highlights
0:03:47
Polatuzumab vedotin in patients with LBCL who have relapsed after CAR-T therapy
Комментарии